147 related articles for article (PubMed ID: 31760122)
1. Oxidative damage in mitochondrial fatty acids oxidation disorders patients and the in vitro effect of l-carnitine on DNA damage induced by the accumulated metabolites.
de Moraes MS; Guerreiro G; Sitta A; de Moura Coelho D; Manfredini V; Wajner M; Vargas CR
Arch Biochem Biophys; 2020 Jan; 679():108206. PubMed ID: 31760122
[TBL] [Abstract][Full Text] [Related]
2. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
[TBL] [Abstract][Full Text] [Related]
3. L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders.
Ribas GS; Vargas CR; Wajner M
Gene; 2014 Jan; 533(2):469-76. PubMed ID: 24148561
[TBL] [Abstract][Full Text] [Related]
4. Oxidative damage in glutaric aciduria type I patients and the protective effects of l-carnitine treatment.
Guerreiro G; Faverzani J; Jacques CED; Marchetti DP; Sitta A; de Moura Coelho D; Kayser A; Kok F; Athayde L; Manfredini V; Wajner M; Vargas CR
J Cell Biochem; 2018 Dec; 119(12):10021-10032. PubMed ID: 30129250
[TBL] [Abstract][Full Text] [Related]
5. Experimental evidence of oxidative stress in patients with l-2-hydroxyglutaric aciduria and that l-carnitine attenuates in vitro DNA damage caused by d-2-hydroxyglutaric and l-2-hydroxyglutaric acids.
Rodrigues DGB; de Moura Coelho D; Sitta Â; Jacques CED; Hauschild T; Manfredini V; Bakkali A; Struys EA; Jakobs C; Wajner M; Vargas CR
Toxicol In Vitro; 2017 Aug; 42():47-53. PubMed ID: 28396261
[TBL] [Abstract][Full Text] [Related]
6. Medium-chain fatty acids accumulating in MCAD deficiency elicit lipid and protein oxidative damage and decrease non-enzymatic antioxidant defenses in rat brain.
Schuck PF; Ferreira GC; Moura AP; Busanello EN; Tonin AM; Dutra-Filho CS; Wajner M
Neurochem Int; 2009 Jul; 54(8):519-25. PubMed ID: 19428797
[TBL] [Abstract][Full Text] [Related]
7. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR
Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137
[TBL] [Abstract][Full Text] [Related]
8. Selective Screening of Fatty Acids Oxidation Defects and Organic Acidemias by Liquid Chromatography/tandem Mass Spectrometry Acylcarnitine Analysis in Brazilian Patients.
Vargas CR; Ribas GS; da Silva JM; Sitta A; Deon M; de Moura Coelho D; Wajner M
Arch Med Res; 2018 Apr; 49(3):205-212. PubMed ID: 30119976
[TBL] [Abstract][Full Text] [Related]
9. Prevention by L-carnitine of DNA damage induced by 3-hydroxy-3-methylglutaric and 3-methylglutaric acids and experimental evidence of lipid and DNA damage in patients with 3-hydroxy-3-methylglutaric aciduria.
Delgado CA; Balbueno Guerreiro GB; Diaz Jacques CE; de Moura Coelho D; Sitta A; Manfredini V; Wajner M; Vargas CR
Arch Biochem Biophys; 2019 Jun; 668():16-22. PubMed ID: 31047871
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies.
Wajner M; Amaral AU
Biosci Rep; 2015 Nov; 36(1):e00281. PubMed ID: 26589966
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial β-oxidation of saturated fatty acids in humans.
Adeva-Andany MM; Carneiro-Freire N; Seco-Filgueira M; Fernández-Fernández C; Mouriño-Bayolo D
Mitochondrion; 2019 May; 46():73-90. PubMed ID: 29551309
[TBL] [Abstract][Full Text] [Related]
12. Deuterated palmitate-driven acylcarnitine formation by whole-blood samples for a rapid diagnostic exploration of mitochondrial fatty acid oxidation disorders.
Dessein AF; Fontaine M; Dobbelaere D; Mention-Mulliez K; Martin-Ponthieu A; Briand G; Vamecq J
Clin Chim Acta; 2009 Aug; 406(1-2):23-6. PubMed ID: 19422814
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience.
Maguolo A; Rodella G; Dianin A; Nurti R; Monge I; Rigotti E; Cantalupo G; Salviati L; Tucci S; Pellegrini F; Molinaro G; Lupi F; Tonin P; Pasini A; Campostrini N; Ion Popa F; Teofoli F; Vincenzi M; Camilot M; Piacentini G; Bordugo A
Mol Genet Metab Rep; 2020 Sep; 24():100632. PubMed ID: 32793418
[TBL] [Abstract][Full Text] [Related]
14. Patients with medium-chain acyl-coenzyme a dehydrogenase deficiency have impaired oxidation of fat during exercise but no effect of L-carnitine supplementation.
Madsen KL; Preisler N; Orngreen MC; Andersen SP; Olesen JH; Lund AM; Vissing J
J Clin Endocrinol Metab; 2013 Apr; 98(4):1667-75. PubMed ID: 23426616
[TBL] [Abstract][Full Text] [Related]
15. Heat stress deteriorates mitochondrial beta-oxidation of long-chain fatty acids in cultured fibroblasts with fatty acid beta-oxidation disorders.
Li H; Fukuda S; Hasegawa Y; Purevsuren J; Kobayashi H; Mushimoto Y; Yamaguchi S
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1669-72. PubMed ID: 20207594
[TBL] [Abstract][Full Text] [Related]
16. l-Carnitine protects against 1,4-benzoquinone-induced apoptosis and DNA damage by suppressing oxidative stress and promoting fatty acid oxidation in K562 cells.
Sun R; Man Z; Ji J; Ji S; Xu K; Pu Y; Yu L; Zhang J; Yin L; Pu Y
Environ Toxicol; 2020 Oct; 35(10):1033-1042. PubMed ID: 32478940
[TBL] [Abstract][Full Text] [Related]
17. Disruption of redox homeostasis in cerebral cortex of developing rats by acylcarnitines accumulating in medium-chain acyl-CoA dehydrogenase deficiency.
Tonin AM; Grings M; Knebel LA; Zanatta Â; Moura AP; Ribeiro CA; Leipnitz G; Wajner M
Int J Dev Neurosci; 2012 Aug; 30(5):383-90. PubMed ID: 22472139
[TBL] [Abstract][Full Text] [Related]
18. DNA damage induced by alloisoleucine and other metabolites in maple syrup urine disease and protective effect of l-carnitine.
Hauschild TC; Guerreiro G; Mescka CP; Coelho DM; Steffens L; Moura DJ; Manfredini V; Vargas CR
Toxicol In Vitro; 2019 Jun; 57():194-202. PubMed ID: 30853490
[TBL] [Abstract][Full Text] [Related]
19. C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects.
Gregersen N; Wintzensen H; Christensen SK; Christensen MF; Brandt NJ; Rasmussen K
Pediatr Res; 1982 Oct; 16(10):861-8. PubMed ID: 7145508
[TBL] [Abstract][Full Text] [Related]
20. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
